| abstract |
The present invention relates to sexual dysfunction such as female sexual dysfunction (FSD), in particular female sexual arousal disorder (FSAD), hyposexual desire disorder (HSDD; lack of interest in sex), female It aims to treat and / or prevent male orgasmic disorders (FOD; non-orgasmic); and male sexual dysfunction, particularly male erectile dysfunction (MED). Male sexual dysfunction includes ejaculation disorders such as premature ejaculation, lack of pleasure (impossible orgasm), or desire disorders such as impaired sexual desire (HSDD; lack of interest in sex). The present invention is also directed to treating neuropsychiatric disorders and neurodegenerative disorders. The present invention provides a compound of formula (I) which is a kind of dopamine agonist, more specifically a kind of agonist that is selective for D3 compared to D2. [Selection figure] None |